Importantly, our bioinformatic analysis suggests that GDF15 overexpression may have a positive impact on the survival of GC patients, but when GDF15 overexpression is accompanied by the upregulation of its effectors from GDF15-GFRAL-RET axis, this seems to correlate with poorer OS. Here, GFRAL is linked to gastric cancer.